From: Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with mucopolysaccharidosis II (Hunter syndrome)
N (%)
Ab+ (n = 19)
PAb+ (n = 16)
NAb+ (n = 15)
PNAb+ (n = 14)
Total (n = 28)
Ab+
--
16 (100)
15 (100)
14 (100)
19 (68)
PAb+
16 (84)
14 (93)
16 (57)
NAb+
15 (79)
14 (88)
15 (54)
PNAb+
14 (74)
14 (50)